Apposite makes Hollowood a star
This article was originally published in Scrip
Executive Summary
Apposite Capital, specialist healthcare investment firm, has promoted Dr Chris Hollowood to partner. Dr Hollowood joined Apposite in 2007 and has been managing some of the firm's primary investments as well as establishing its direct secondary activities, an area it plans to expand. He is currently a member of the board of directors of Anaphore, Convergence Pharmaceuticals and Zonare Medical Systems. Previously, Dr Hollowood was a fund manager with Neptune Management, with responsibility for Healthcare sector investments, before moving into healthcare focused venture capital and corporate advisory at Bioscience Managers.